The Semmelweis Study: a longitudinal occupational cohort study within the framework of the Semmelweis Caring University Model Program for supporting healthy aging

Zoltan Ungvari*, Adam G. Tabák, Roza Adany*, György Purebl, Csilla Kaposvári, Vince Fazekas-Pongor, Tamás Csípő, Zsófia Szarvas, Krisztián Horváth, Peter Mukli, Piroska Balog, Robert Bodizs, Peter Ujma, Adrienne Stauder, Daniel W. Belsky, Illés Kovács, Andriy Yabluchanskiy, Andrea B. Maier, Mariann Moizs, Piroska ÖstlinYongjie Yon, Péter Varga, Zoltán Vokó, Magor Papp, István Takács, Barna Vásárhelyi, Péter Torzsa, Péter Ferdinandy, Anna Csiszar, Zoltán Benyó, Attila J. Szabó, Gabriella Dörnyei, Mika Kivimäki, Miklos Kellermayer, Bela Merkely

*Corresponding author for this work

Research output: Contribution to JournalReview articleAcademicpeer-review

Abstract

The Semmelweis Study is a prospective occupational cohort study that seeks to enroll all employees of Semmelweis University (Budapest, Hungary) aged 25 years and older, with a population of 8866 people, 70.5% of whom are women. The study builds on the successful experiences of the Whitehall II study and aims to investigate the complex relationships between lifestyle, environmental, and occupational risk factors, and the development and progression of chronic age-associated diseases. An important goal of the Semmelweis Study is to identify groups of people who are aging unsuccessfully and therefore have an increased risk of developing age-associated diseases. To achieve this, the study takes a multidisciplinary approach, collecting economic, social, psychological, cognitive, health, and biological data. The Semmelweis Study comprises a baseline data collection with open healthcare data linkage, followed by repeated data collection waves every 5 years. Data are collected through computer-assisted self-completed questionnaires, followed by a physical health examination, physiological measurements, and the assessment of biomarkers. This article provides a comprehensive overview of the Semmelweis Study, including its origin, context, objectives, design, relevance, and expected contributions.

Original languageEnglish
Pages (from-to)191-218
Number of pages28
JournalGeroScience
Volume46
Issue number1
Early online date7 Dec 2023
DOIs
Publication statusPublished - Feb 2024

Bibliographical note

Publisher Copyright:
© 2023, The Author(s).

Funding

Funding for the initial infrastructure and the baseline data collection of the study has been provided by a series of grants obtained from the Ministry of Innovation and Technology of Hungary, the National Research, Development and Innovation Fund, the European University for Well-Being (EUniWell) program, and by the leadership of Semmelweis University through the allocation of resources for the purposes of the study. Once the cohort is assembled, continuing support will be sought from Semmelweis University and national and international funding organizations. The leadership team of the Semmelweis Study will apply for research funding from a variety of sponsors, including the National Research, Development and Innovation Fund, the Hungarian Academy of Sciences, the European Research Council, and private foundations. The goal is to secure funding to allow for an increasingly rich data collection in the upcoming phases through personal contact with the cohort participants. Open access funding provided by Semmelweis University. Project no. TKP2021-NKTA-47 has been implemented with the support provided by the Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund, financed under the TKP2021-NKTA funding scheme. Funding for the project through the National Cardiovascular Laboratory Program (RRF-2.3.1–21-2022–00003) was provided by the Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund. Project no. 135784 has also been implemented with the support provided from the National Research, Development and Innovation Fund of Hungary, financed under the K_20 funding scheme. This work was also supported by grants from the National Research, Development and Innovation Office (RRF-2.3.1-NKL), the Hungarian Academy of Sciences (TK2016-78) and the European University for Well-Being (EUniWell) program (grant agreement number: 101004093/ EUniWell/EAC-A02-2019 / EAC-A02-2019–1). The project has received funding from the HUN-REN Hungarian Research Network (TKCS-2021/32). Dr Adam Tabák was supported by the UK Medical Research Council (S011676), NordForsk (the Nordic Research Programme on Health and Welfare, 75021). Dr. Daniel W. Belsky is a fellow of the CIFAR CBD Network. Dr Mika Kivimäki is supported by the Wellcome Trust (221854/Z/20/Z), the Medical Research Council (R024227, S011676), the National Institute on Aging (R01AG056477, R01AG062553), and Academy of Finland (350426). Drs. Anna Csiszar, Zoltan Ungvari, Peter Mukli and Andriy Yabluchanskiy were supported by the National Institute on Aging (RF1AG072295, R01AG055395, R01AG068295; R01AG070915, R03AG070479), the National Institute of Neurological Disorders and Stroke (R01NS100782), the National Cancer Institute (R01CA255840), the Oklahoma Shared Clinical and Translational Resources (U54GM104938) with an Institutional Development Award (IDeA) from NIGMS, the Presbyterian Health Foundation, the Reynolds Foundation, the Oklahoma Nathan Shock Center (P30AG050911), and the Cellular and Molecular GeroScience CoBRE (P20GM125528). The funding sources had no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.

FundersFunder number
Presbyterian Health Foundation
National Institute of General Medical Sciences
Ministry of Innovation and Technology
Semmelweis Egyetem
Ministry of Innovation and Technology of Hungary
European Research Council
Richard S. Reynolds Foundation
Wellcome Trust221854/Z/20/Z, 221854
Nemzeti Kutatási Fejlesztési és Innovációs HivatalRRF-2.3.1-NKL
National Institute of Neurological Disorders and StrokeR01NS100782
NordForsk75021
Medical Research CouncilMR/S011676/1, R024227, S011676
National Cancer InstituteR01CA255840
Academy of FinlandR01AG070915, R01AG068295, R01AG055395, RF1AG072295, R03AG070479
Oklahoma Shared Clinical and Translational ResourcesU54GM104938
National Cardiovascular Laboratory ProgramRRF-2.3.1–21-2022–00003, 135784
European University for Well-Being101004093/ EUniWell/EAC-A02-2019 / EAC-A02-2019–1
National Health and Medical Research Council350426
HUN-REN Hungarian Research NetworkTKCS-2021/32
Magyar Tudományos AkadémiaTK2016-78
Oklahoma Nathan Shock CenterP30AG050911
National Institute on AgingR01AG062553, R01AG056477
Nemzeti Kutatási, Fejlesztési és Innovaciós AlapTKP2021-NKTA-47
Cellular and Molecular GeroScience CoBREP20GM125528

    Keywords

    • Age-associated diseases
    • Biological age
    • Central Europe
    • Epidemiology
    • Health Promoting University
    • Healthy aging
    • Workplace cohort

    Fingerprint

    Dive into the research topics of 'The Semmelweis Study: a longitudinal occupational cohort study within the framework of the Semmelweis Caring University Model Program for supporting healthy aging'. Together they form a unique fingerprint.

    Cite this